Authors:
Kuschel, B
Gayther, SA
Easton, DF
Ponder, BAJ
Pharoah, PDP
Citation: B. Kuschel et al., Apparent human BRCAI knockout caused by mispriming during polymerase chainreaction: Implications for genetic testing, GENE CHROM, 31(1), 2001, pp. 96-98
Authors:
Reynolds, L
Jones, K
Winton, DJ
Cranston, A
Houghton, C
Howard, L
Ponder, BAJ
Smith, DP
Citation: L. Reynolds et al., C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET, ONCOGENE, 20(30), 2001, pp. 3986-3994
Authors:
Antoniou, AC
Pharoah, PDP
McMullan, G
Day, NE
Ponder, BAJ
Easton, D
Citation: Ac. Antoniou et al., Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study, GENET EPID, 21(1), 2001, pp. 1-18
Authors:
Daigo, Y
Chin, SF
Gorringe, KL
Bobrow, LG
Ponder, BAJ
Pharoah, PDP
Caldas, C
Citation: Y. Daigo et al., Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers - A new approach for the molecular analysis of paraffin-embedded cancer tissue, AM J PATH, 158(5), 2001, pp. 1623-1631
Authors:
Werness, BA
Parvatiyar, P
Ramus, SJ
Whittemore, AS
Garlinghouse-Jones, K
Oakley-Girvan, I
DiCioccio, RA
Wiest, J
Tsukada, Y
Ponder, BAJ
Piver, MS
Citation: Ba. Werness et al., Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53, J NAT CANC, 92(13), 2000, pp. 1088-1091
Authors:
Lakhani, SR
Gusterson, BA
Jacquemier, J
Sloane, JP
Anderson, TJ
van de Vijver, MJ
Venter, D
Freeman, A
Antoniou, A
McGuffog, L
Smyth, E
Steel, CM
Haites, N
Scott, RJ
Goldgar, D
Neuhausen, S
Daly, PA
Ormiston, W
McManus, R
Scherneck, S
Ponder, BAJ
Futreal, PA
Peto, J
Stoppa-Lyonnet, D
Bignon, YJ
Struewing, JP
Bishop, DT
Klijn, JGM
Devilee, P
Cornelisse, CJ
Lasset, C
Lenoir, G
Barkardottir, RB
Egilsson, V
Hamann, U
Chang-Claude, J
Sobol, H
Weber, B
Easton, DF
Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Authors:
Healey, CS
Dunning, AM
Teare, MD
Chase, D
Parker, L
Burn, J
Chang-Claude, J
Mannermaa, A
Kataja, V
Huntsman, DG
Pharoah, PDP
Luben, RN
Easton, DF
Ponder, BAJ
Citation: Cs. Healey et al., A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability, NAT GENET, 26(3), 2000, pp. 362-364
Authors:
Gayther, SA
Batley, SJ
Linger, L
Bannister, A
Thorpe, K
Chin, SF
Daigo, Y
Russell, P
Wilson, A
Sowter, HM
Delhanty, JDA
Ponder, BAJ
Kouzarides, T
Caldas, C
Citation: Sa. Gayther et al., Mutations truncating the EP300 acetylase in human cancers, NAT GENET, 24(3), 2000, pp. 300-303
Authors:
Brown, J
Coulthard, A
Dixon, AK
Dixon, JM
Easton, DF
Eeles, RA
Evans, DGR
Gilbert, FG
Hayes, C
Jenkins, JPR
Leach, MO
Moss, SM
Padhani, AP
Pointon, LJ
Ponder, BAJ
Sloane, JP
Turnbull, LW
Walker, LG
Warren, RML
Watson, W
Citation: J. Brown et al., Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer, BREAST, 9(2), 2000, pp. 72-77
Authors:
Brown, J
Coulthard, A
Dixon, AK
Dixon, JM
Easton, DF
Eeles, RA
Evans, DGR
Gilbert, FG
Hayes, C
Jenkins, JPR
Leach, MO
Moss, SM
Padhani, AP
Pointon, LJ
Ponder, BAJ
Sloane, JP
Turnbull, LW
Walker, LG
Warren, RML
Watson, W
Citation: J. Brown et al., Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer, BREAST, 9(2), 2000, pp. 78-82
Authors:
Pharoah, PDP
Lipscombe, JM
Redman, KL
Day, NE
Easton, DF
Ponder, BAJ
Citation: Pdp. Pharoah et al., Familial predisposition to breast cancer in a British population: implications for prevention, EUR J CANC, 36(6), 2000, pp. 773-779
Authors:
Brown, J
Buckley, D
Coulthard, A
Dixon, AK
Dixon, JM
Easton, DF
Eeles, RA
Evans, DGR
Gilbert, FG
Graves, M
Hayes, C
Jenkins, JPR
Jones, AP
Keevil, SF
Leach, MO
Liney, GP
Moss, SM
Padhani, AR
Parker, GJM
Pointon, LJ
Ponder, BAJ
Redpath, TW
Sloane, JP
Turnbull, LW
Walker, LG
Warren, RML
Citation: J. Brown et al., Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study, MAGN RES IM, 18(7), 2000, pp. 765-776
Authors:
Healey, CS
Dunning, AM
Durocher, F
Teare, D
Pharoah, PDP
Luben, RN
Easton, DF
Ponder, BAJ
Citation: Cs. Healey et al., Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk, CARCINOGENE, 21(2), 2000, pp. 189-193
Authors:
Piver, MS
Tsukada, Y
Werness, BA
DiCioccio, RA
Whittemore, AS
Ponder, BAJ
Citation: Ms. Piver et al., Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: A study by the Gilda Radner Familial Ovarian Cancer Registry, GYNECOL ONC, 78(2), 2000, pp. 166-170
Authors:
Werness, BA
Ramus, SJ
Whittemore, AS
Garlinghouse-Jones, K
Oakley-Girvan, I
DiCioccio, RA
Tsukada, Y
Ponder, BAJ
Piver, MS
Citation: Ba. Werness et al., Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations, HUMAN PATH, 31(11), 2000, pp. 1420-1424
Authors:
Sutcliffe, S
Pharoah, PDP
Easton, DF
Ponder, BAJ
Citation: S. Sutcliffe et al., Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer, INT J CANC, 87(1), 2000, pp. 110-117